Related references
Note: Only part of the references are listed.Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
Valerie M. Vaughn et al.
CLINICAL INFECTIOUS DISEASES (2021)
Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit
Charlotte Vanhomwegen et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2021)
Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019
Michael May et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
Isabell Pink et al.
INFECTION (2021)
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
Emma J. Kooistra et al.
CRITICAL CARE (2021)
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship
Kathrin Rothe et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data
Paulo Ricardo Martins-Filho et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Co-infections in people with COVID-19: a systematic review and meta-analysis
Louise Lansbury et al.
JOURNAL OF INFECTION (2020)
How covid-19 is accelerating the threat of antimicrobial resistance
Jeremy Hsu
BMJ-BRITISH MEDICAL JOURNAL (2020)
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Bradley J. Langford et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
Lang Wang et al.
JOURNAL OF INFECTION (2020)
Bacterial and fungal superinfections in critically ill patients with COVID-19
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2020)
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
Damien Contou et al.
ANNALS OF INTENSIVE CARE (2020)
Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
Miranda van Berkel et al.
CRITICAL CARE (2020)
Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences
Danielle L. Burke et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Alejandro H. Rodriguez et al.
JOURNAL OF INFECTION (2016)
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection
O. Burkhardt et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care
Matthias Briel et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Share Paper
